S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

Pacira Biosciences Price Target & Analyst Ratings (NASDAQ:PCRX)

$43.81
-0.13 (-0.30 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$43.66
Now: $43.81
$44.86
50-Day Range
$42.40
MA: $44.70
$46.78
52-Week Range
$34.64
Now: $43.81
$49.50
Volume288,850 shs
Average Volume493,747 shs
Market Capitalization$1.83 billion
P/E Ratio1,095.25
Dividend YieldN/A
Beta1.16

Analyst Ratings

Pacira Biosciences (NASDAQ:PCRX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for Pacira Biosciences in the last 12 months. Their average twelve-month price target is $53.73, suggesting that the stock has a possible upside of 22.64%. The high price target for PCRX is $85.00 and the low price target for PCRX is $38.00. There are currently 1 sell rating, 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.542.502.502.44
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.73$53.10$55.67$55.07
Price Target Upside: 22.64% upside13.83% upside47.70% upside26.63% upside

Pacira Biosciences (NASDAQ:PCRX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Pacira Biosciences (NASDAQ:PCRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/23/2020SunTrust BanksInitiated CoverageBuy$60.00Low
1/7/2020WedbushReiterated RatingBuy$85.00Low
12/18/2019Royal Bank of CanadaReiterated RatingBuyLow
11/8/2019BarclaysBoost Price TargetOverweight$52.00 ➝ $55.00Medium
11/7/2019Needham & Company LLCReiterated RatingBuy$56.00High
11/7/2019CowenReiterated RatingHold$41.00High
11/6/2019BTIG ResearchInitiated CoverageBuy$56.00 ➝ $56.00Medium
10/8/2019Jefferies Financial GroupSet Price TargetBuy$60.00Low
8/9/2019Stifel NicolausSet Price TargetHold$42.00Low
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$46.00 ➝ $43.00Low
5/6/2019MizuhoUpgradeUnderperform ➝ Neutral$29.00 ➝ $38.00Low
4/9/2019Piper Jaffray CompaniesSet Price TargetBuy$55.00Low
2/12/2019National SecuritiesInitiated CoverageSellMedium
11/2/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $50.00Low
11/2/2018HC WainwrightBoost Price TargetBuy$60.00High
11/1/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Buy$56.00 ➝ $63.00High
10/10/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$46.00 ➝ $48.00High
10/2/2018Canaccord GenuitySet Price TargetHold ➝ Hold$45.00 ➝ $49.00Low
5/17/2018OppenheimerReiterated RatingHoldLow
4/8/2018Seaport Global SecuritiesSet Price TargetBuy$48.00Medium
(Data available from 1/24/2018 forward)
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: VIX - Volatility Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel